The order book remained solid with 3.1x TTM revenue while, the total outstanding order book increased by 15 per cent YoY and stood at Rs 6,682 crore as on September 30, 2019. The company expects an order inflow of Rs 1,500 crore in the remaining quarters of FY20, mainly from irrigation and highways.

The market opened in the green on February 13, 2020, overall volumes in futures & options currently stand at 1.79 crore contracts with a turnover of Rs. 13,02,740.38 crore.

The market opened in the green on February 13, 2020. The previous trading session witnessed the Sensex going up by 349.76 points to end at 41,565.90 and the Nifty was up by 93.30 points to close at 12,201.20. 

The market opened in the green on February 13, 2020. The previous trading session witnessed the Sensex going up by 349.76 points to end at 41,565.90 and the Nifty was up by 93.30 points to close at 12,201.20. 

Titan has acquired smart devices manufacturer-Hug Innovations Corp. to focus on the fast-growing wearable market.

Its standalone revenue for the quarter came in at Rs 206.88 crore as against Rs 153.23 crore in the corresponding quarter last year, registering 35 per cent YoY increase.

A follow through move is required to instill more confidence in the recent breakout. As long as Nifty trades above 12,160-12,175 region, it would be a buy on the dips market. Stocks in news: General Insurance Corporation of India, PNC Infratech, BHEL, Aurobindo Pharma, Yes Bank, Welspun Corp, Rico Auto.

After witnessing gains for two consecutive sessions, the bulls might be pushed on back foot and Indian markets may open on a soft note as the coronavirus fear is likely to re-emerge. Along with this, the weak macro data, which was released yesterday post market, could take its toll.

The following stocks will be in focus during Thursday's trading session in the light of their result announcements-Allcargo Logistics, Apollo Hospitals, Atul Auto, BPCL and Century Plyboards.

Dr Reddy and Wockhardt informed the bourses today that they have entered into a definitive agreement in which Dr Reddy would acquire select divisions of Wockhardt branded generics business in India and a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives